Come up with a name for your new list and we'll add to it:
Aimm Therapeutics raised a round of funding on June 05, 2009. Investors include
Life Sciences Fund Amsterdam.
AIMM is a biotech company spun-out of the Netherlands Cancer Institute and the Academic Medical Center at the University of Amsterdam. The company aims to develop high quality human monoclonal antibod…